Therefore, to identify FASN-mediated vulnerabilities which can be efficiently targeted in cancer, it is very important to understand the contribution of FASN to CRC initiation in the context of the in vivo in a mouse model with ad libitum feeding. This evidence concerns the gene FASN and colorectal carcinoma.